A newly approved ‘living drug’ could save more cancer patients’ lives
https://www.sciencenews.org/article/newly-approved-drug-save-cancer-patient #medicine #treatment #cancer #TCellTherapy #SolidTumors #TILs #Amtagvi #lifileucel
A newly approved ‘living drug’ could save more cancer patients’ lives
https://www.sciencenews.org/article/newly-approved-drug-save-cancer-patient #medicine #treatment #cancer #TCellTherapy #SolidTumors #TILs #Amtagvi #lifileucel
Gilead bets on Xilio cancer drug as biotech restructures—Sanders blasts Novo Nordisk for ‘outrageous’ price of Ozempic, Wegovy—Boundless Bio breaks IPO lull with $100M fundraise--http://bit.ly/w28kSd #gileadsciences #solidtumors #berniesanders #drugpricing #novonordisk #ozempic #wegovy #ipos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
AbbVie CEO Richard Gonzalez to step down, Robert Michael to succeed him —Medtronic lifts annual profit forecast, exits ventilator business—FDA approves Iovance's Amtagvi as first T-cell therapy for a solid tumor--http://bit.ly/w28kSd #abbvie #ceos #medtech #medtronic #earnings #ventilators #solidtumors #fda #tcelltherapy #iovance #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Roche drops oral eye disease drug after completing phase 2, pulls back from solid tumor bispecific-- Lilly links up European ADC network, snagging Elahere rival in latest biotech buy --Pfizer to pay $2M settlement for alleged gender wage discrimination -- See more on our front page news http://bit.ly/w28kSd #roche #solidtumors #elililly #mergersandacquisitions #pfizer #genderdiscrimination #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Referenced link: https://medicalxpress.com/news/2023-03-potential-strategy-cell-therapy-solid.html
Discuss on https://discu.eu/q/https://medicalxpress.com/news/2023-03-potential-strategy-cell-therapy-solid.html
Originally posted by Phys.org / @physorg_com: http://nitter.platypush.tech/medical_xpress/status/1636091665877172229#m
RT by @physorg_com: Study offers a potential strategy to improve T cell therapy in #solidtumors @pennmedicine @PNASNews https://pnas.org/doi/10.1073/pnas.2218632120 https://medicalxpress.com/news/2023-03-potential-strategy-cell-therapy-solid.html
Referenced link: https://medicalxpress.com/news/2023-03-liquid-biopsy-pediatric-solid-tumors.html
Discuss on https://discu.eu/q/https://medicalxpress.com/news/2023-03-liquid-biopsy-pediatric-solid-tumors.html
Originally posted by Phys.org / @physorg_com: http://nitter.platypush.tech/medical_xpress/status/1631664743638335489#m
RT by @physorg_com: Researchers develop #liquidbiopsy test for pediatric #solidtumors @childrensLA @nresearchnews https://www.nature.com/articles/s41698-023-00357-0 https://medicalxpress.com/news/2023-03-liquid-biopsy-pediatric-solid-tumors.html
New data: One of the few randomized controlled trials #RCT for the #treatment of #COVID19 shows effects for patients with #hematologic malignancies or #solidtumors with more immunological analyses upcoming! #Oncology #immunology #cancer
https://www.nature.com/articles/s43018-022-00503-w
#safety #celltherapy #celltherapies #immunotherapy #genetherapy #cellulartherapeutics #IO #cancer #oncology #dlbcl #lymphoma #cartecells #cartcellrx #nkcells #nkcars #bispecifics #tcellengagers #bloodcancers #lymphoma #multiplemyeloma #solidtumors #Breastcancer #GIcancer #cartcell #cartcells #cartcellrx #msc #mesenchymalstemcells #mesenchymalstemcell #CRISPR #crisprcas9 #genetherapy #geneediting #checkpointinhibitors #bmt #bmtrx #bmtsm #tcellrx
Concise & timely review from my colleague Sarah Reed out in #AACR #ClinicalCancerResearch about #ClonalHematopoiesis in #SolidTumors. See the nice summary figure below and find the full text here: https://aacrjournals.org/clincancerres/article-abstract/doi/10.1158/1078-0432.CCR-22-2598/711363/CHIP-Happens-Clonal-hematopoiesis-of-indeterminate #medicine #science #hematology #oncology #cancer #immunology
Two important papers on #talazoparib and #avelumab in #solidtumors. Take home messsage: BRCA is associated with most responses and no clear advantage of combo over monotherapy with a caveat of being careful about cross-trial comparisons